Current status and prospects of targeted therapies non-small cell lung cancer

Article Properties
Cite
Svatoň, Martin. “Current Status and Prospects of Targeted Therapies Non-Small Cell Lung Cancer”. Onkologie, vol. 10, no. 1, 2016, pp. 15-18, https://doi.org/10.36290/xon.2016.005.
Svatoň, M. (2016). Current status and prospects of targeted therapies non-small cell lung cancer. Onkologie, 10(1), 15-18. https://doi.org/10.36290/xon.2016.005
Svatoň M. Current status and prospects of targeted therapies non-small cell lung cancer. Onkologie. 2016;10(1):15-8.
Refrences
Title Journal Journal Categories Citations Publication Date
Monitoring tumor-derived cell-free DNA in patients with solid tumors: Clinical perspectives and research opportunities Cancer Treatment Reviews
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 80
The latest therapeutic strategies after resistance to first generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients with non-small cell lung cancer (NSCLC) Annals of Translational Medicine
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2015
ALK inhibitors in non-small cell lung cancer: crizotinib and beyond 2014
Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer Journal of Thoracic Disease
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
  • Medicine: Medicine (General)
 2013
Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosinekinase inhibitors Anticancer Research
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 2010